RamSoft and Therapixel Join Forces for Enhanced Imaging Technology
RamSoft Inc. is excited to announce its commercial partnership with Therapixel, a leader in AI-driven medical imaging technology. This collaboration will integrate Therapixel's cutting-edge MammoScreen® software directly into RamSoft's established PowerServer™ and OmegaAI® platforms. This initiative is set to enhance the workflow of radiologists and improve the overall quality of cancer detection services.
Bringing Advanced AI Capabilities to Radiologists
The partnership is designed to provide RamSoft clients with seamless access to advanced AI functionalities, which are crucial for improving diagnostic accuracy in breast imaging. The introduction of MammoScreen® within RamSoft's framework aims to streamline the workflow of radiologists, thereby enhancing efficiency and patient care.
This Integration Marks a Major Milestone
The integration of MammoScreen® will allow radiologists using RamSoft's software to harness the power of AI directly within their existing workflows. This collaboration signifies a major step forward in the desire to improve the detection of breast cancer and boost the productivity of radiologists.
Features of MammoScreen®
MammoScreen® is equipped with several AI-driven capabilities that significantly enhance the breast imaging process:
- Pre-check – This feature ensures the image quality is optimal and confirms important patient information before the radiologist begins reading the images.
- Cancer Detection – It offers a thorough analysis to detect and characterize lesions, incorporating previous imaging findings along with breast density assessments.
- Pre-reporting – This functionality automates the entry of structured results into existing reporting systems, effectively reducing the time and effort needed for documentation.
These features promise to enhance the user experience significantly while providing tangible benefits in terms of efficiency, allowing radiologists to focus more on patient care than administrative tasks.
Proven Results from Clinical Studies
Recent studies on MammoScreen® have showcased its potential to improve radiologist performance markedly. The use of this tool has led to notable increases in sensitivity and specificity during screenings, alongside significant reductions in reading and reporting times. For instance, studies suggest an 8% increase in sensitivity and a 2% improvement in specificity, not to mention an impressive 24% reduction in reporting times. Furthermore, the ability to identify screen-detectable cancers one and two years prior has also been positively highlighted.
A Commitment to Innovation and Clinical Efficiency
This partnership not only emphasizes the commitment of both RamSoft and Therapixel to innovate in the healthcare space, but also underscores the importance of open platforms in broadening access to advanced medical AI tools. Now, radiologists will be able to utilize MammoScreen® as a fully integrated feature within their existing PACS workflows, eliminating the need for additional systems or interfaces.
About RamSoft
RamSoft is a notable global provider focused on delivering innovative cloud-based radiology software solutions designed for various imaging centers and radiology departments. Over 750 sites and numerous clients worldwide utilize PowerServer™, which offers a flexible and scalable architecture, allowing medical professionals to take full advantage of comprehensive RIS/PACS capabilities. Their latest offering, OmegaAI®, ensures that medical facilities can leverage rapid, secure, and efficient cloud-based solutions without any footprint concerns, all while being powered by Microsoft Azure.
About Therapixel
Therapixel specializes in AI-enhanced medical imaging software, aiming to furnish healthcare professionals with precise and timely information. Known for winning the Digital Mammography DREAM Challenge in 2017, the company has created MammoScreen®, which improves the interpretation of both 2D and 3D mammograms. This tool assists radiologists in boosting their performance and confidence, thereby enabling quicker reassurances for patients.
Frequently Asked Questions
1. What is the significance of RamSoft's partnership with Therapixel?
This partnership aims to integrate advanced AI features into RamSoft’s imaging software, enhancing cancer detection and radiologist workflow efficiency.
2. What functionalities does MammoScreen® provide?
MammoScreen® includes features like pre-check, cancer detection analysis, and pre-reporting, all designed to streamline the imaging process.
3. How does this collaboration impact radiologists’ workflows?
This integration simplifies workflows for radiologists by embedding AI capabilities directly into existing systems, thus enhancing clinical productivity.
4. Are there any clinical studies supporting MammoScreen®'s effectiveness?
Yes, clinical studies have shown improvements in sensitivity and specificity, as well as reductions in reading time associated with MammoScreen®.
5. What are the long-term goals of this partnership?
The ultimate aim is to enhance diagnostic confidence, improve breast imaging services, and increase access to leading-edge medical AI technologies.
